% | $
Quotes you view appear here for quick access.

Nxstage Medical, Inc. Message Board

  • Hax44 Hax44 Mar 2, 2010 9:07 AM Flag

    NxStage(R) and Dirinco Sign Distribution Agreement

    LAWRENCE, Mass., March 2 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq:NXTM - News), a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Dirinco, an independent company, for the promotion, sale, delivery and service of certain NxStage and Medisystems products in the Netherlands.

    Under the terms of the agreement, the NxStage System One and PureFlow™ SL dialysate preparation system will be available to dialysis centers throughout the Netherlands exclusively through Dirinco. Dirinco will also make available the System One for use in critical care applications, and has the option to make NxStage Medisystems ButtonHole needles available to its customers in this region.

    "We are pleased to announce this new opportunity to provide more patients access to our life-changing products while expanding our international presence," stated John Mullen, Vice President and General Manager, International, NxStage Medical, Inc. "We look forward to working closely with Dirinco, a company with a long history of successfully introducing new technologies and therapies to the Dutch market."

    "As many dialysis patients in this region seek alternative treatments to in-center dialysis, we believe there is a real opportunity to advance home hemodialysis in the Netherlands," said Roel Kuiper, Managing Director of Dirinco. "Through our agreement with NxStage, our customers will gain access to this innovative technology and the quality of life and clinical benefits daily therapy with the System One has been reported to offer."

    About Dirinco

    The Dutch Dirinco Group, with subsidiaries in Belgium and Switzerland (Citra-Lock), is a company, with innovative products and services mainly in the areas of chronicle and acute hemodialysis. Dirinco is a privately held company, with almost 25 years of experience in production and marketing of healthcare products. Over the years, Dirinco has become an expert in extracorporeal circulation treatment of renal failure. Today the company holds a leading position in the acute renal (CRRT) market in the Netherlands and supplies all Dutch dialysis clinics with several innovative products. Dirinco has strong relationships with nephrologists, intensivists, management, pharmacies and purchase departments of hospital organizations. The company has a direct Benelux sales and service organization and offers its innovations through a network of dedicated distributors to the remaining international markets.

18.84+0.52(+2.84%)May 27 4:00 PMEDT